Abstract:Background: Benign prostatic hyperplasia (BPH) is a common disease in elderly men and is often accompanied by chronic inflammation. Macrophages (several subtypes) are the main inflammatory cells that infiltrate the hyperplastic prostate and are found to secrete cytokines and growth factors. The current study aims to explore the effect of M2a macrophages on the development of BPH via insulin-like growth factor 1 (IGF-1). Methods: Human prostate tissues, prostate, and monocyte cell lines (WPMY-1, BPH-1, and THP-1) were used. THP-1 was polarized into several subtypes with cytokines. The expression and localization of IGF-1 and M2 macrophages were determined via immunofluorescent staining, quantitative real-time polymerase chain reaction, and Western blot analysis. Flow cytometry and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays were used to investigate the effects of different subtypes of macrophages on prostate cells. IGF-1 in WPMY-1 and BPH-1 cells was silenced and cocultured with or without M2a macrophages. Cell proliferation, apoptosis, cell cycle, epithelial-mesenchymal transition (EMT), and fibrosis processes were examined. Results: The polarized subtypes of macrophages were verified by amplifying their specific markers. M2a macrophages enhanced prostate cell proliferation more significantly and CD206 was more expressed in hyperplastic prostate. IGF-1 was localized in both epithelial and stromal components of prostate and upregulated in BPH tissues. M2a macrophages expressed more IGF-1 than other subtypes. Knockdown of IGF-1 in WPMY-1 and BPH-1 cells attenuated cell proliferation, promoted cell apoptosis, retarded cell cycle at the G0/G1 phase, and suppressed the EMT process in BPH-1 cells as well as the fibrotic process in WPMY-1 cells, which was reversible when cocultured with M2a macrophages. Conclusion: These data demonstrated that knockdown of IGF-1 expression in cultured BPH epithelial and stromal cells reduces proliferation and increases apoptosis. These effects are reversed by coculture with M2a macrophages.

Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway

High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression

17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostatic hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation

Role of P-Erk1/2 in Benign Prostatic Hyperplasia During Hyperinsulinemia.

The Association Between Insulin Resistance and Prostatic Hyperplasia

A Preliminary Study of the Impact of Insulin Resistance on the Growth of the Prostate in Patients with Benign Prostatic Hyperplasia

The Relationship Between Glucose Homeostasis Status and Prostate Size in Aging Chinese Males with Benign Prostatic Hyperplasia

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives

Relationship between diabetes mellitus and benign prostatic hyperplasia

M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown

Hypoxia-inducible Factor 1α (Hif-1Α) Mediates the Epithelial-Mesenchymal Transition in Benign Prostatic Hyperplasia.

Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse

High Glucose Promotes Pancreatic Cancer Cell Proliferation Via the Induction of EGF Expression and Transactivation of EGFR

The expression of transforming growth factor-β and the apoptosis in the prostate of the experimental diabetes rats

Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial‐mesenchymal transition

Effects of Metformin on Prostatic Tissue of Rats with Metabolic Syndrome and Benign Prostatic Hyperplasia.

Association of Type 2 Diabetes Mellitus with Pathological Grade of Prostate Cancer and Prostate-Specific Antigen

Comparison of the Regulatory Effects of Flavonoids and Saponins from Eclipta Prostrate on Insulin Resistance in HepG2 Cells

Capsaicin reduces blood glucose and prevents prostate growth by regulating androgen, RAGE/IGF-1/Akt, TGF-β/Smad signalling pathway and reversing epithelial-mesenchymal transition in streptozotocin-induced diabetic mice

Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation